InvestorsHub Logo

crudeoil24

05/01/19 9:34 AM

#221 RE: crudeoil24 #220

Pacira BioSciences shares are trading higher after competitor Heron Therapeutics' marketing application for a pain treatment was rejected by the FDA.
Benzinga